VIM- and IMP-type metallo-β-lactamase-producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals

Emerging Infectious Diseases

Volumn 9, Issue 7, 2003, Pages 868-871

  Lee, Kyungwon ^a   Lee, Wee Gyo ^b   Uh, Young ^c   Ha, Gyoung Yim ^d   Cho, Jihyun ^e   Chong, Yunsop ^a   Kang, Jung Oak ^f   Kim, Moon Yeon ^f   Lee, Nam Yong ^f   Kim, Mi Na ^f   Kim, Myungshin ^f   Song, Kyung Soon ^f   Hong, Ki Sook ^f   Paik, In Ki ^f   Lee, Hye Soo ^f   Jang, Sook Jin ^f   Park, Ae Ja ^f   Kang, Sung Ha ^f   Song, Won Keun ^f   Rheem, Insoo ^f   Kim, Eui Chong ^f   Park, Yeon Joon ^f   Shin, Jong Hee ^f   Kang, Myungseo ^f   Sun, Young Kyu ^f   Lee, Hee Joo ^f   Lim, Hwan Sub ^f   Lee, Jong Wook ^f   Shin, Bo Moon ^f   more..

^a Yonsei University College of Medicine   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Yonsei University Wonju College of Medicine   (South Korea)

^d Dongguk University College of Medicine   (South Korea)

^e Wonkwang University   (South Korea)

^f Yonsei Univ College of Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; BETA LACTAMASE; IMIPENEM; METALLO BETA LACTAMASE; UNCLASSIFIED DRUG;

ACINETOBACTER; ALLELE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; DRUG SENSITIVITY; ENZYME SYNTHESIS; HOSPITAL; HUMAN; KOREA; NONHUMAN; PSEUDOMONAS;

EID: 0038386534     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0907.030012     Document Type: Article

References (16)

1. Osano E, Arakawa Y, Wacharotayankun R, Ohta M, Horii T, Ito H, et al. Molecular characterization of an enterobacterial metallo-β-lactamases found in a clinical isolates of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother 1994;38:71-8.
2. IMP-1. Antimicrob Agents Chemother 2002;46:255-8.
3. VIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother 1999; 43:1584-90.
4. VIM-2 cassette-containing novel integrons in metallo-β-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital. Antimicrob Agents Chemother 2002;46:1053-8.
5. Yan J-J, Hsueh P-R, Ko W-C, Luh E-T, Tsai S-H, Wu H-M, et al. Metallo-β-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob Agents Chemother 2001;45:2224-8.
6. Tolman MA, Rolston K, Jones RN, Walsh TR. Molecular characterization of VIM-4, a novel metallo-beta-lactamase isolated from Texas: report from the cancer surveillance program (2001). Proceedings of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract C1-1851. San Diego, California; 2002.
7. Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo T-D, et al. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother 2000;44:891-7.
8. Richet HM, Mohammed J, McDonald LC, Jarvis WR, INSPEAR. Building communication networks: International Network for the Study and Prevention of Emerging Antimicrobial Resistance. Emerg Infect Dis 2001;7:319-22.
9. Molland ES, Black JA, Ourada J, Reisbid MD, Hanson ND, Thomson KS. Occurrence of newer β-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals. Antimicrob Agents Chemother 2002;46:3837-42.
10. Lee K, Lee HS, Jang SJ, Park AJ, Lee MH, Song WK, et al. Antimicrobial resistance surveillance of bacteria in 1999 in Korea with a special reference to resistance of enterococci to vancomycin and gram-negative bacilli to third generation cephalosporin, imipenem, and fluoroquinolone. J Korean Med Sci 2001;16:262-70.
11. Kiska DL, Gilligan PH. Pseudomonas. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology, 7th ed. Washington: American Society for Microbiology; 1999. p. 517-25.
12. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Eleventh informational supplement. NCCLS document M100-S11. Wayne (PA): The Committee, 2001.
13. Lee K, Chong Y, Shin HB, Kim YA, Yong D, Yum JH. Modified Hodge test and EDTA-disk synergy tests to screen metallo-β-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect 2001;7:88-91.
14. Takahashi A, Yomoda S, Kobayashi I, Kubo T, Tsunoda M, Iyobe S. Detection of carbapenemase-producing Acinetobacter baumannii in a hospital. J Clin Microbiol 2000;38:526-9.
15. Rasmussen BA, Bush K. Carbapenem-hydrolyzing β-lactamases. Antimicrob Agents Chemother 1997;41:223-32.
16. Cornaglia G, Mazzariol A, Lauretti L, Rossolini GM, Fontana R. Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-β-lactamase. Clin Infect Dis 2000;31:1119-25.